 | | Vol.11.27 – 24 July, 2020 |
| |
|
|
| Researchers found a significant metabolic shift in SUCLA2-deleted prostate cancer cells, including lower mitochondrial respiratory activity.
[Oncogene] |
|
|
|
 | | PUBLICATIONSRanked by the impact factor of the journal |
|
|
|
| Investigators provided evidence that PLK1-dependent phosphorylation of FOXO1 induced its nuclear exclusion and negatively regulated FOXO1′s transcriptional activity in prostate cancer.
[Scientific Reports] |
|
|
|
| Using prostate cancer cell lines with different androgen receptor composition, the authors systematically manipulated somatic proteins of the Bromodomain and ExtraTerminal (BET) family to determine which BET proteins influence EMT.
[Prostate Cancer and Prostatic Diseases] |
|
|
|
| Both non-coding RNA activated by DNA damage silencing and miR-495-3p upregulation accelerated cell apoptosis and curbed cell proliferation, migration, and invasion in prostate cancer cells.
[Cancer Cell International] |
|
|
|
| Compounds were evaluated for their effect on cell cycle distribution and changes to cancer metabolism in LNCaP prostate cancer cells using a multiparametric quantitative single-cell imaging approach.
[Journal of Natural Products] |
|
|
|
| Scientists compared murine xenografts of human prostate cancer LNCaP cells with those of more aggressive PC3 cells.
[Nmr in Biomedicine] |
|
|
|
| PC3 and DU145 cells were transfected with RBBP6 siRNAs to examine the biological characteristics. Anisomycin with/without RBBP6 siRNA was used to treat PC3 cells for further investigating the ramification of the RBBP6‐mediated JNK pathway in prostate cancer.
[Cell Biology International] |
|
|
|
|
| Prostate cancer patients’ management demands prioritization, adjustments, and a tailored approach during the unprecedented SARS-CoV-2 pandemic. Benefit of care from treatment must be carefully weighed against the potential of infection and morbidity from COVID-19.
[Prostate Cancer and Prostatic Diseases] |
|
|
|
|
| RedHill Biopharma Ltd. announced approval from the Ministry of Health of the Russian Federation for its Clinical Trial Authorization application for a Phase II/III study evaluating opaganib in patients hospitalized with severe SARS-CoV-2 infection and pneumonia.
[RedHill Biopharma Ltd.] |
|
|
|
| The French government this week unveiled a draft science bill that promises to increase public research spending with an extra €25 billion over the next ten years.
[ScienceInsider] |
|
|
|
| Four Chinese nationals have been charged with visa fraud after revelations that they sent information on the layout of US labs and research carried out by colleagues back to China.
[The Scientist] |
|
|
|
|
| August 27 – August 29
Virtual |
|
|
|
|
|
| | Rutgers Cancer Institute of New Jersey – Rutgers, New Jersey, United States |
|
|
|
| | European Molecular Biology Laboratory – Hinxton, Cambridge, United Kingdom |
|
|
|
| | University of Maryland, Baltimore – Baltimore, Maryland, United States |
|
|
|
| | West Virginia University – Morgantown, West Virginia, United States |
|
|
|
| | Stanford Institute for Stem Cell Biology and Regenerative Medicine – Stanford, California, United States |
|
|
|
|
Cancer Stem Cell News
Cell Therapy News
Dermal Cell News
Endothelial Cell News
ESC & iPSC News
Extracellular Matrix News
Hematopoiesis News
Hepatic Cell News
Human Immunology News
Immune Regulation News
Intestinal Cell News
Mammary Cell News
Mesenchymal Cell News
Muscle Cell News
Neural Cell News
Organoid News
Pancreatic Cell News
Prostate Cell News
Pulmonary Cell News
